Services Will Support Healthcare Readiness for Military Personnel
PLYMOUTH MEETING, Pa., Oct. 21 /PRNewswire/ -- IMS HEALTH (NYSE: RX)
reported today that the Defense Supply Center Philadelphia (DSCP), U.S.
Department of Defense, included the company in the award of the Commercial
Asset Visibility (CAV) contract. With the goal of supporting the overall
readiness of the Military's pharmaceutical inventory, the timeframe of the
contract is 10 years -- one year plus nine option years. IMS HEALTH is the
world's leading provider of information solutions to the pharmaceutical and
healthcare industries.
IMS HEALTH Services to Improve Precision of Military's Pharmaceuticals
Inventory
The Department of Defense initiative supports the military's mobilization
needs by ensuring that pharmaceutical access and use are based on the most
current utilization guidelines and comprehensive information on commercially
accessible inventories. IMS HEALTH is one of the key strategic partners
chosen by the Department of Defense for the program.
The program implements healthcare readiness by relying on rapid supply
from existing commercial pharmaceutical distribution infrastructures, instead
of government-maintained pharmaceutical inventories. IMS HEALTH's
comprehensive information of pharmaceutical-flows through the commercial
marketplace is imperative for planning and execution of logistical support in
this just-in-time environment.
IMS HEALTH services will enable the military to:
-- Ensure they plan for commercially accepted and commercially supportable
pharmaceutical products;
-- Identify and correct shortfalls in their pharmaceutical distribution
system by monitoring the commercial market and usage patterns as
compared to the requirements of the Armed Services, by identifying what
is and is not available, and by developing alternate solutions to
offset production shortfalls; and
-- Ensure full readiness for the surge in pharmaceutical requirements
during war situations.
Defense Supply Center Philadelphia
The Defense Supply Center Philadelphia is a Primary Field Level Activity
of the Defense Logistics Agency, U.S. Department of Defense. Their vision is
"to be the worldwide provider of federal logistical services, champion of
military readiness, and a leader in business innovation providing food,
clothing and textiles, medical supplies and equipment." To fulfill this
mission, they are putting in place multiple acquisition strategies to meet the
demands of peacetime operations, humanitarian relief efforts, lesser
contingencies and Major Theater Wars (MTWs).
IMS HEALTH
IMS HEALTH is the world's leading provider of information solutions to the
pharmaceutical and healthcare industries. With more than $1 billion in 1997
revenue, IMS HEALTH operates in over 90 countries. IMS HEALTH is the largest
pharmaceutical manufacturer information partner, with over 40 years'
experience in the industry. Key products and services integral to customer
day-to-day operations include: market research for prescription and
over-the-counter pharmaceutical products; sales management information to
optimize sales force productivity; technology enabled selling solutions for
sales and marketing decision-making; technologies systems and information
services that support managed care organizations.
Additional information and previous press releases are available at IMS
HEALTH's web site: http://www.imshealth.com.
SOURCE IMS HEALTH
 back to top
Related links:
http://www.imshealth.com
Company News On-Call:
http://www.prnewswire.com/comp/115785.html or fax,
800-758-5804, ext. 115785
CONTACT:
Nancy Duckwitz of IMS HEALTH, 610-834-5338
|
